These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16054060)

  • 1. Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis.
    Bates SH; Kulkarni RN; Seifert M; Myers MG
    Cell Metab; 2005 Mar; 1(3):169-78. PubMed ID: 16054060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRb-STAT3 signaling is required for the neuroendocrine regulation of energy expenditure by leptin.
    Bates SH; Dundon TA; Seifert M; Carlson M; Maratos-Flier E; Myers MG
    Diabetes; 2004 Dec; 53(12):3067-73. PubMed ID: 15561935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance.
    Bodary PF; Shen Y; Ohman M; Bahrou KL; Vargas FB; Cudney SS; Wickenheiser KJ; Myers MG; Eitzman DT
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):70-6. PubMed ID: 17095713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 signalling is required for leptin regulation of energy balance but not reproduction.
    Bates SH; Stearns WH; Dundon TA; Schubert M; Tso AW; Wang Y; Banks AS; Lavery HJ; Haq AK; Maratos-Flier E; Neel BG; Schwartz MW; Myers MG
    Nature; 2003 Feb; 421(6925):856-9. PubMed ID: 12594516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRb signals act within a distributed network of leptin-responsive neurones to mediate leptin action.
    Leinninger GM; Myers MG
    Acta Physiol (Oxf); 2008 Jan; 192(1):49-59. PubMed ID: 18171429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice.
    Chua SC; Liu SM; Li Q; Sun A; DeNino WF; Heymsfield SB; Guo XE
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E384-92. PubMed ID: 14600075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice.
    Barouch LA; Berkowitz DE; Harrison RW; O'Donnell CP; Hare JM
    Circulation; 2003 Aug; 108(6):754-9. PubMed ID: 12885755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity.
    Coppari R; Ichinose M; Lee CE; Pullen AE; Kenny CD; McGovern RA; Tang V; Liu SM; Ludwig T; Chua SC; Lowell BB; Elmquist JK
    Cell Metab; 2005 Jan; 1(1):63-72. PubMed ID: 16054045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene.
    Nonogaki K; Strack AM; Dallman MF; Tecott LH
    Nat Med; 1998 Oct; 4(10):1152-6. PubMed ID: 9771748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the neuroendocrine control of energy homeostasis by adiposity signals during aging.
    Carrascosa JM; Ros M; Andrés A; Fernández-Agulló T; Arribas C
    Exp Gerontol; 2009; 44(1-2):20-5. PubMed ID: 18572339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis.
    Dhillon H; Zigman JM; Ye C; Lee CE; McGovern RA; Tang V; Kenny CD; Christiansen LM; White RD; Edelstein EA; Coppari R; Balthasar N; Cowley MA; Chua S; Elmquist JK; Lowell BB
    Neuron; 2006 Jan; 49(2):191-203. PubMed ID: 16423694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin induces IL-1 receptor antagonist expression in the brain.
    Hosoi T; Okuma Y; Nomura Y
    Biochem Biophys Res Commun; 2002 Jun; 294(2):215-9. PubMed ID: 12051696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Tyr to Phe and fa/fa leptin receptor mutations in the PC12 cell line.
    Eyckerman S; Waelput W; Verhee A; Broekaert D; Vandekerckhove J; Tavernier J
    Eur Cytokine Netw; 1999 Dec; 10(4):549-56. PubMed ID: 10586122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
    van den Hoek AM; Teusink B; Voshol PJ; Havekes LM; Romijn JA; Pijl H
    J Neuroendocrinol; 2008 Jan; 20(1):120-7. PubMed ID: 18081560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue in offspring of Lepr(db/+) mice: early-life environment vs. genotype.
    Lambin S; van Bree R; Caluwaerts S; Vercruysse L; Vergote I; Verhaeghe J
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E262-71. PubMed ID: 16954332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic beta-cells prevents progression of diabetes in db/db mice.
    Miyawaki K; Inoue H; Keshavarz P; Mizuta K; Sato A; Sakamoto Y; Moritani M; Kunika K; Tanahashi T; Itakura M
    Diabetes Res Clin Pract; 2008 Oct; 82(1):33-41. PubMed ID: 18678431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor Stat3 is dispensable for pancreatic beta-cell development and function.
    Lee JY; Hennighausen L
    Biochem Biophys Res Commun; 2005 Sep; 334(3):764-8. PubMed ID: 16026757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.
    Inoue H; Ogawa W; Asakawa A; Okamoto Y; Nishizawa A; Matsumoto M; Teshigawara K; Matsuki Y; Watanabe E; Hiramatsu R; Notohara K; Katayose K; Okamura H; Kahn CR; Noda T; Takeda K; Akira S; Inui A; Kasuga M
    Cell Metab; 2006 Apr; 3(4):267-75. PubMed ID: 16581004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.
    Netea MG; Joosten LA; Lewis E; Jensen DR; Voshol PJ; Kullberg BJ; Tack CJ; van Krieken H; Kim SH; Stalenhoef AF; van de Loo FA; Verschueren I; Pulawa L; Akira S; Eckel RH; Dinarello CA; van den Berg W; van der Meer JW
    Nat Med; 2006 Jun; 12(6):650-6. PubMed ID: 16732281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
    Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A
    Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.